It is important to note that the observed changes in gene expression are consistent with the lipid phenotypes seen in SIOD patients and the elevated blood TG levels observed in SmarcAL1 KO mice. This evidence concerns the gene SMARCAL1 and Schimke immuno-osseous dysplasia.